Open AccessEfficacy and Safety of a Quadruple Combination Combivir + Abacavir + Efavirenz Regimen in Antiretroviral Treatment–Naive HIV-1–Infected Adults: La Francilienne
Author(s) -
Pierre de Truchis,
Gilles Force,
Yves Welker,
Denis Méchali,
M Pulik,
K Chemlal,
É. Rouveix,
Alain Devidas,
Danielle Praindhui,
Jean-Philippe Mamet
Publication year - 2002
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/00126334-200210010-00008
Subject(s) - abacavir , efavirenz , regimen , medicine , viral load , adverse effect , population , gastroenterology , human immunodeficiency virus (hiv) , immunology , antiretroviral therapy , environmental health
To evaluate the safety and efficacy of a protease inhibitor sparing, quadruple therapy (Combivir + abacavir + efavirenz) in antiretroviral treatment-naive HIV-1-infected adults.